Literature DB >> 22914806

A randomized study of coronary artery bypass surgery performed with the Resting Heart™ System utilizing a low vs a standard dosage of heparin.

Johan Nilsson1, Sara Scicluna, Gunnar Malmkvist, Leif Pierre, Lars Algotsson, Per Paulsson, Henrik Bjursten, Per Johnsson.   

Abstract

OBJECTIVES: Allogeneic blood transfusion and reoperation for postoperative bleeding after the coronary artery bypass grafting have a negative impact on the patient outcome. This study aimed at evaluating the effects of reduced doses of heparin and protamine on the patient outcome, using a heparin-coated mini-cardiopulmonary bypass (CPB) system.
METHODS: Sixty patients undergoing elective first-time CPB were prospectively randomized either to have a reduced systemic heparinization [activated clotting time (ACT) = 250 s] or to a control group perfused with a full heparin dose (ACT = 420 s). Blood transfusions, ventilation time, early postoperative bleeding, ICU stay, reoperations for bleeding, postoperative cognitive status and the level of mobilization were registered.
RESULTS: Twenty-nine patients were randomized to the control group, 27 patients to the low-dose group and 4 patients were excluded because of protocol violations. Four patients in the control group received a total of 10 units of packed red blood cells, and in the low-dose group, no transfusions were given, P = 0.046. No patient was reoperated because of bleeding. The ICU stay was significantly shorter in the low-dose group (8.4 vs 13.7 h, P = 0.020), less dependent on oxygen on the first postoperative day (78 vs 97%, P = 0.034), better mobilized (89 vs 59%, P = 0.006) and had less pain (visual analogue scale 2.0 vs 3.5, P = 0.019) compared with the control group.
CONCLUSIONS: The use of a mini-CPB system combined with a low dose of heparin reduced the need for blood transfusions and may facilitate the faster mobilization of the patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914806      PMCID: PMC3480612          DOI: 10.1093/icvts/ivs345

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  25 in total

1.  Hemostatic efficacy of a fibrin sealant-based topical agent in a femoral artery injury model: a randomized, blinded, placebo-controlled study.

Authors:  M R Jackson; S A Friedman; A J Carter; V Bayer; J R Burge; M J MacPhee; W N Drohan; B M Alving
Journal:  J Vasc Surg       Date:  1997-08       Impact factor: 4.268

2.  Complement activation by heparin-protamine complexes during cardiopulmonary bypass: effect of C4A null allele.

Authors:  K A Shastri; G L Logue; M P Stern; S Rehman; S Raza
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

3.  Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.

Authors:  Jens Wippermann; Johannes M Albes; Martin Hartrumpf; Mirko Kaluza; Rüdiger Vollandt; Raimund Bruhin; Thorsten Wahlers
Journal:  Eur J Cardiothorac Surg       Date:  2005-07       Impact factor: 4.191

4.  Heparin-coated extracorporeal circulation with full and low dose heparinization: comparison of thrombin related coagulatory effects.

Authors:  N Mirow; T Brinkmann; K Minami; G Tenderich; K Kleesiek; R Körfer
Journal:  Artif Organs       Date:  2001-06       Impact factor: 3.094

5.  Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting.

Authors:  Eivind Øvrum; Geir Tangen; Stein Tølløfsrud; Bjørn Skeie; Mari Anne L Ringdal; Reidar Istad; Rolf Øystese
Journal:  J Thorac Cardiovasc Surg       Date:  2010-08-14       Impact factor: 5.209

6.  Clinical advantages of using mini-bypass systems in terms of blood product use, postoperative bleeding and air entrainment: an in vivo clinical perspective.

Authors:  Mathias Perthel; Lémir El-Ayoubi; Andreas Bendisch; Joachim Laas; Markus Gerigk
Journal:  Eur J Cardiothorac Surg       Date:  2007-03-06       Impact factor: 4.191

7.  Variation in use of blood transfusion in coronary artery bypass graft surgery.

Authors:  Elliott Bennett-Guerrero; Yue Zhao; Sean M O'Brien; T B Ferguson; Eric D Peterson; James S Gammie; Howard K Song
Journal:  JAMA       Date:  2010-10-13       Impact factor: 56.272

8.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  BMJ       Date:  2010-03-23

9.  Heparin-coated circuit during cardiopulmonary bypass. A clinical study using closed circuit, centrifugal pump and reduced heparinization.

Authors:  O F Sellevold; T M Berg; K A Rein; O W Levang; O J Iversen; K Bergh
Journal:  Acta Anaesthesiol Scand       Date:  1994-05       Impact factor: 2.105

10.  Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: a clinical study.

Authors:  J W Borowiec; A Bylock; J van der Linden; S Thelin
Journal:  Ann Thorac Surg       Date:  1993-06       Impact factor: 4.330

View more
  5 in total

Review 1.  Use of minimal invasive extracorporeal circulation in cardiac surgery: principles, definitions and potential benefits. A position paper from the Minimal invasive Extra-Corporeal Technologies international Society (MiECTiS).

Authors:  Kyriakos Anastasiadis; John Murkin; Polychronis Antonitsis; Adrian Bauer; Marco Ranucci; Erich Gygax; Jan Schaarschmidt; Yves Fromes; Alois Philipp; Balthasar Eberle; Prakash Punjabi; Helena Argiriadou; Alexander Kadner; Hansjoerg Jenni; Guenter Albrecht; Wim van Boven; Andreas Liebold; Fillip de Somer; Harald Hausmann; Apostolos Deliopoulos; Aschraf El-Essawi; Valerio Mazzei; Fausto Biancari; Adam Fernandez; Patrick Weerwind; Thomas Puehler; Cyril Serrick; Frans Waanders; Serdar Gunaydin; Sunil Ohri; Jan Gummert; Gianni Angelini; Volkmar Falk; Thierry Carrel
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-01-26

2.  Is elimination of cardiotomy suction preferable in aortic valve replacement? Assessment of perioperative coagulation, fibrinolysis and inflammation.

Authors:  Akimasa Morisaki; Atsushi Nakahira; Yasuyuki Sasaki; Hidekazu Hirai; Yuko Okada; Shigefumi Suehiro; Toshihiko Shibata
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-31

3.  A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling.

Authors:  Daniel C Leslie; Anna Waterhouse; Julia B Berthet; Thomas M Valentin; Alexander L Watters; Abhishek Jain; Philseok Kim; Benjamin D Hatton; Arthur Nedder; Kathryn Donovan; Elana H Super; Caitlin Howell; Christopher P Johnson; Thy L Vu; Dana E Bolgen; Sami Rifai; Anne R Hansen; Michael Aizenberg; Michael Super; Joanna Aizenberg; Donald E Ingber
Journal:  Nat Biotechnol       Date:  2014-10-12       Impact factor: 54.908

4.  Emergency Valve Replacement Under Minimal Cardiopulmonary Bypass for a Patient With Infective Endocarditis and Large Brain Hematoma: A Case Report.

Authors:  Gabor Kiss; Eric Braunberger
Journal:  A A Pract       Date:  2018-03-15

5.  miR-3064-5p and miR-4745-5p affect heparin sensitivity in patients undergoing cardiac surgery by regulating AT-III and factor X mRNA levels.

Authors:  Hai-Ping Ma; Min Fu; Maisitanguli Masula; Chang-Shuang Xing; Qiang Zhou; Jing-Tong Tan; Jiang Wang
Journal:  Front Physiol       Date:  2022-08-12       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.